Welcome, Guest. Please login or register.
January 18, 2018, 03:10:38 AM

Login with username, password and session length

  • Total Posts: 725242
  • Total Topics: 59114
  • Online Today: 294
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 3
Guests: 97
Total: 100


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Progress, no big breakthrough, in hunt for HIV cure  (Read 2372 times)

0 Members and 1 Guest are viewing this topic.

Offline ichigo_kun

  • Member
  • Posts: 49
Progress, no big breakthrough, in hunt for HIV cure
« on: March 11, 2012, 11:50:11 AM »
Progress, no big breakthrough, in hunt for HIV cure
By Deena Beasley
Sun Mar 11, 2012 9:05am EDT
By Deena Beasley

(Reuters) - Scientists, stymied for decades by the complexity of the human immunodeficiency virus, are making progress on several fronts in the search for a cure for HIV infections, a leading medical research conference was told this week in Seattle.

Promising tactics range from flushing hidden HIV from cells to changing out a person's own immune system cells, making them resistant to HIV and then putting them back into the patient's body.

A major stumbling block is the fact that HIV lies low in pools or reservoirs of latent infection that even powerful drugs cannot reach, scientists told the Conference on Retroviruses and Opportunistic Infections, one of the world's largest scientific meetings on HIV/AIDS.

"We need to get the virus to come out of the latent state, then rely on the immune system or some other treatment to kill the virus," said Dr. Kevin De Cock, director of the Center for Global Health at the U.S. Centers for Disease Control and Prevention.

HIV, which surfaced more than 30 years ago, infects more than 33 million people worldwide. Thanks to prevention measures, tests that detect HIV early and new antiretroviral drugs that can control the virus for decades, infection with the virus that causes AIDS is no longer a death sentence.

Still, questions of cost, side effects, drug resistance and ultimate lifespan, make lifelong use of antiviral drugs a less-than-ideal solution.

The International AIDS Society last year formally added the aim of finding a cure to its HIV strategy of prevention, treatment and care.

Early human trials of vaccines designed to prevent or treat infection with the difficult to target virus have proved disappointing. HIV is a "provirus" that is integrated into the DNA of a host cell, where it can remain latent or eventually reactivate.

"It has proven to be an incredibly formidable challenge to develop a vaccine," said John Coffin, professor of molecular biology at Tufts University in Boston. "In recent years the pendulum is swinging back."

Scientific advances in molecular engineering are allowing researchers to delve more deeply into the mechanism of HIV.

"Vaccines work by recognizing the surface of the virus and eliminating it," said Dr. Dennis Burton, professor of immunology and microbial science at the Scripps Research Institute in La Jolla, California. "HIV is a highly evolved virus that has developed a surface incorporating features to avoid antibody responses," including instability.

He presented research showing that "broadly neutralizing antibodies" can be designed to recognize and penetrate HIV, giving researchers new vaccine targets.

Merck & Co presented data showing for the first time that its cancer drug Zolinza, also known as vorinostat, can disrupt latent HIV infection.

"Once you have a validated approach you can really go back to the drawing board in the labs and design molecules more suited to therapy," said Daria Hazuda, vice president for infectious disease discovery at Merck.

She said the company is currently exploring how to design future studies.

"The sobering fact is that only one competent provirus in one tissue could reseed the entire infection," said Dr. John Mellors, chief of the infectious disease division at the University of Pittsburgh.

Phillip Gregory, chief scientific officer at Sangamo BioSciences, said he was not "fanatically optimistic about priming the immune system to fight HIV" with a preventive vaccine.

He explained that because HIV is a "reverse transcriptase" virus it is constantly mutating, making it very difficult for the body's immune system to keep up. Vaccines induce the production of antibodies that recognize and bind to very specific viral surface molecules, but the HIV molecules end up with a variety of subtle molecular differences on their surface.

"Eradication is a very tough theoretical sell," he said. "What's going to work is getting to the point that we could reasonably expect the immune system to get it totally under control."

Sangamo is conducting two mid-stage trials of its gene therapy in which infection-fighting white blood cells known as CD4 cells are removed, manipulated to knock out the CCR5 gene used by HIV to infect cells and then replaced.

"The change is permanent. Those cells and their progeny will go on to carry that genetic change," said Geoffrey Nichol, head of research and development at Sangamo.

An earlier study of a single infusion of the gene therapy in six HIV-infected patients showed mixed results, eliminating the virus in one patient with a naturally occurring gene mutation.

In the newer trials, according to Sangamo, patients will first be treated with an agent that reduces the number of lymphocytes in the bone marrow. The aim is to prime the immune system to take up more of the genetically modified CD4 cells when they are returned to the patient.

(Reporting By Deena Beasley; Editing by Gary Hill)


Offline Dr.Strangelove

  • Member
  • Posts: 215
Re: Progress, no big breakthrough, in hunt for HIV cure
« Reply #1 on: March 12, 2012, 05:41:55 AM »
An earlier study of a single infusion of the gene therapy in six HIV-infected patients showed mixed results, eliminating the virus in one patient with a naturally occurring gene mutation.

This is somewhat imprecise. Sangamo doesn't seem to say much about the actual numbers but from what I understood from their press release the vial load was reduced in all patients but only one patient went actually undetectable.
That doesn't mean that the virus was 'eliminated' though. I doubt he will stay undetectable without constant new infustions of his modified CD4 cells.

Offline newt

  • Member
  • Posts: 3,896
  • the one and original newt
Re: Progress, no big breakthrough, in hunt for HIV cure
« Reply #2 on: March 13, 2012, 06:00:03 PM »
Vorinostat, as proof of concept and even if the agent is not vorinostat, is v interesting. It would be helpful to find a safe (ie already approved for human use) agent that will do the job of kicking HIV out of bed to get finally hammered, it woud save so much time.

This is 1990 folks, so 6-10 year wait for a possible pharma cure (in developed countries at least).

In the deckchair but opening the good Scotch.

- matt
"The object is to be a well patient, not a good patient"


Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.